RRML - Hepcidin: a crucial peptide for normal and pathological iron metabolism

Main page
News
RJLabM Credits
Archive
- Current issue
- Ahead of print
- List of published issues
- 2026
  - Nr.1/2026
- 2025
  - Nr.4/2025
  - Nr.3/2025
  - Nr.2/2025
  - Nr.1/2025
  - Supplement 1/2025
- 2024
  - Nr.4/2024
  - Nr.3/2024
  - Nr.2/2024
  - Nr.1/2024
  - Supplement 1/2024
- 2023
  - Nr.4/2023
  - Nr.3/2023
  - Nr.2/2023
  - Nr.1/2023
  - Supplement 1/2023
- 2022
  - Nr.4/2022
  - Nr.3/2022
  - Nr.2/2022
  - Nr.1/2022
  - Supplement 1/2022
- 2021
  - Nr.4/2021
  - Nr.3/2021
  - Nr.2/2021
  - Nr.1/2021
- 2020
  - Nr.4/2020
  - Nr.3/2020
  - Nr.2/2020
  - Nr.1/2020
  - Supplement 1/2020
- 2019
  - Nr.4/2019
  - Nr.3/2019
  - Nr.2/2019
  - Nr.1/2019
  - Supplement 1/2019
- 2018
  - Nr.4/2018
  - Nr.3/2018
  - Nr.2/2018
  - Nr.1/2018
  - Supplement 1/2018
  - Supplement 2/2018
  - Supplement 3/2018
- 2017
  - Nr.4/2017
  - Nr.3/2017
  - Nr.2/2017
  - Nr.1/2017
  - Supplement 1/2017
- 2016
  - Nr.4/2016
  - Nr.3/2016
  - Nr.2/2016
  - Nr.1/2016
  - Supplement 1/2016
- 2015
  - Nr.4/2015
  - Nr.3/2015
  - Nr.2/2015
  - Nr.1/2015
  - Supplement 1/2015
- 2014
  - Nr.4/2014
  - Nr.3/2014
  - Nr.2/2014
  - Nr.1/2014
  - Supplement 1/2014
- 2013
  - Nr.4/2013
  - Nr.3/2013
  - Nr.2/2013
  - Nr.1/2013
  - Supplement 1/2013
- 2012
  - Nr.4/2012
  - Nr.3/2012
  - Nr.2/2012
  - Nr.1/2012
  - Supplement 1/2012
- 2011
  - Nr.4/2011
  - Nr.3/2011
  - Nr.2/2011
  - Nr.1/2011
  - Supplement 1/2011
- 2010
  - Nr.4/2010
  - Nr.3/2010
  - Nr.2/2010
  - Nr.1/2010
  - Supplement 1/2010
- 2009
  - Nr.4/2009
  - Nr.3/2009
  - Nr.2/2009
  - Nr.1/2009
  - Supplement 1/2009
- 2008
  - Nr.4/2008
  - Nr.3/2008
  - Nr.2/2008
  - Nr.1/2008
  - Supplement 1/2008
- 2007
  - Nr.4/2007
  - Nr.3/2007
  - Nr.2/2007
  - Nr.1/2007
- 2006
  - Nr.4/2006
  - Nr.3/2006
  - Nr.2/2006
  - Nr.1/2006
- 2005
  - Nr.1/2005
Instructions for authors
Online applications
- Send an article
- Online payments
Editorial
About us
Links

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12

Top 10 downloaded articles - February 2026 -

Hematologic predictors of in-h...	8
The evaluation of a diagnostic...	7
Functional insights into a rar...	7
Serum Beta-Klotho as a damage-...	7
Establishment of intra- and in...	7
New immunodiagnostic tests for...	6
Comparative analysis of the im...	6
Effects of nitroglycerin combi...	4
Mechanistic study of novel ary...	4
Romanian Review of Laboratory ...	3

Concept, Design & Programming
Dr. Adrian Man

Nr. 10(1)/2008

Hepcidin: a crucial peptide for normal and pathological iron metabolism

Mariana Paţiu, Gabriel Laszlo

Abstract:

The recently discovered liver hormone hepcidin appears to be the central regulator of iron homeostasis. It offers a unifying explanation for as different abnormalities in iron metabolism as those seen in anemia of chronic disease and hereditary hemochromatosis and a better understanding of how iron absorption and distribution are regulated in health and in certain diseases. Besides hepcidin’s potential use in diagnosis, hepcidin agonists and antagonists may prove valuable in disease prevention and therapy.

Keywords: hepcidin,iron homeostasis,hereditary hemochromatosis,anemia in chronic disease

Download full text PDF
(44 KB)

Paţiu M, Laszlo G. Hepcidin: a crucial peptide for normal and pathological iron metabolism. Rev Romana Med Lab. 2008;10(1):22-4